DataString Consulting Company Logo
DataString Consulting Company Logo
Mrsa Pcr Detection Kit Market
Request Free Sample
Home»Recent Reports»Mrsa Pcr Detection Kit Market

Mrsa Pcr Detection Kit Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1804095, Published - August 2025

Segmented in Product Type (Real-Time, Conventional, Digital), Applications (Clinical Diagnostics, Research Laboratories, Pharmaceutical, Forensic Laboratories, Others), Technology, Sensitivity and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Mrsa Pcr Detection Kit Market Outlook

The market for Mrsa Pcr Detection Kit was estimated at $1.2 billion in 2024; it is anticipated to increase to $1.9 billion by 2030, with projections indicating growth to around $2.7 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 7.4% over the forecast period. The MRSA PCR Detection Kit remains essential for healthcare because it helps detect Methicillin-resistant Staphylococcus aureus infections at an early stage. The ongoing significance of this kit results from multiple elements which include rising worldwide MRSA infections and molecular diagnostic progress and the urgent requirement for fast accurate diagnostic tools in clinical and research environments. The worldwide fight against antibiotic resistance has demonstrated the critical need for these detection kits because they enable healthcare providers to develop appropriate treatment plans and stop MRSA transmission.


The MRSA PCR Detection Kit functions as an advanced diagnostic instrument which enables fast MRSA infection detection to support proper treatment decisions. The Polymerase Chain Reaction technology in this kit provides highly sensitive and specific DNA sequence detection and amplification capabilities which make it an essential tool for MRSA detection. The kit serves multiple purposes across hospital settings and diagnostic laboratories and research facilities.


Market Size Forecast & Key Insights

2019
$1.2B2024
2029
$2.5B2034

Absolute Growth Opportunity = $1.3B

•The Mrsa Pcr Detection Kit market is projected to grow from $1.2 billion in 2024 to $2.5 billion in 2034. This represents a CAGR of 7.4%, reflecting rising demand across Clinical Diagnostics, Research & Development and Food Safety Testing.

•The Mrsa Pcr Detection Kit market is set to add $1.3 billion between 2024 and 2034, with manufacturer targeting Research Laboratories & Pharmaceutical Applications projected to gain a larger market share.

•With Rising incidence of mrsa infections, and Technological advancements in pcr techniques, Mrsa Pcr Detection Kit market to expand 104% between 2024 and 2034.

Opportunities in the Mrsa Pcr Detection Kit Market

Strategic Collaborations

The MRSA PCR Detection Kit market growth will be driven by partnerships between healthcare institutions and research organizations. The partnerships enable clinical trials and improve product visibility and speed up regulatory approvals which expands the market reach of the kit.

Untapped Market Segments and Technological Innovations

The MRSA PCR Detection Kit demonstrates substantial market growth potential in unexplored market segments especially in developing countries. The developing world experiences rising healthcare infrastructure development and growing awareness about Methicillin-resistant Staphylococcus aureus infections which drives demand for diagnostic tools such as the MRSA PCR Detection Kit.

The ongoing development of PCR technologies creates opportunities for the MRSA PCR Detection Kit. The combination of real-time PCR and digital PCR technologies in the kit leads to improved sensitivity and specificity which makes it the preferred choice for MRSA detection.

Growth Opportunities in North America and Asia-Pacific

Asia Pacific Outlook

The Asia-Pacific region offers promising market opportunities for MRSA PCR Detection Kit because MRSA infections are increasing and healthcare spending is rising in China and India. The market faces intense competition between local and international players who include Bio-Rad Laboratories and Qiagen among others. The market expands because diagnostic labs and hospitals adopt PCR technology more frequently while healthcare professionals become more aware of the need to detect MRSA early. The regions market benefits from government programs which enhance healthcare facilities and drive the adoption of sophisticated diagnostic equipment.

North America Outlook

The advanced healthcare infrastructure of North America combined with its high MRSA infection rates makes this region a major market for MRSA PCR Detection Kits. The region experiences rapid growth because of rising demand for quick diagnostic solutions and established market players and their adoption of molecular diagnostic technology advancements. The competitive market includes established companies Roche Diagnostics and Thermo Fisher Scientific which continue to innovate their products to preserve their market leadership position. The region experiences growth because people become more aware of MRSA infections while understanding the necessity of early detection.

North America Outlook

The advanced healthcare infrastructure of North America combined with its high MRSA infection rates makes this region a major market for MRSA PCR Detection Kits. The region experiences rapid growth because of rising demand for quick diagnostic solutions and established market players and their adoption of molecular diagnostic technology advancements. The competitive market includes established companies Roche Diagnostics and Thermo Fisher Scientific which continue to innovate their products to preserve their market leadership position. The region experiences growth because people become more aware of MRSA infections while understanding the necessity of early detection.

Asia-Pacific Outlook

The Asia-Pacific region offers promising market opportunities for MRSA PCR Detection Kit because MRSA infections are increasing and healthcare spending is rising in China and India. The market faces intense competition between local and international players who include Bio-Rad Laboratories and Qiagen among others. The market expands because diagnostic labs and hospitals adopt PCR technology more frequently while healthcare professionals become more aware of the need to detect MRSA early. The regions market benefits from government programs which enhance healthcare facilities and drive the adoption of sophisticated diagnostic equipment.

Growth Opportunities in North America and Asia-Pacific

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : U.S., Germany, UK, Japan, China are expected to grow at 4.8% to 7.1% CAGR

2

Emerging Markets : Brazil, India, South Africa are expected to grow at 8.5% to 10.2% CAGR

Market Analysis Chart

The global market for the MRSA PCR Detection Kit is being propelled by several key drivers. The primary driver is the escalating prevalence of Methicillin-resistant Staphylococcus aureus infections worldwide. This surge in MRSA cases is necessitating the need for rapid, reliable, and accurate diagnostic solutions, thereby fueling the demand for MRSA PCR Detection Kits. Furthermore, advancements in Polymerase Chain Reaction technology and its integration into MRSA detection have significantly improved the speed and accuracy of diagnosis, acting as another major market driver. On the other hand, the market faces certain restraints that could hinder its growth.

Recent Developments and Technological Advancement

December 2024

Bio-Rad Laboratories launched a new MRSA PCR Detection Kit with improved sensitivity and specificity, expanding their diagnostic product portfolio

October 2024

Thermo Fisher Scientific announced a strategic partnership with a leading hospital chain to provide MRSA PCR Detection Kits for rapid and accurate detection of MRSA in patients

August 2024

Roche Diagnostics introduced an advanced MRSA PCR Detection Kit, incorporating next-generation sequencing technology for enhanced detection accuracy.

The MRSA PCR Detection Kit market has seen significant advancements in recent years. This growth is primarily driven by the increasing prevalence of Methicillin-resistant Staphylococcus aureus infections worldwide, necessitating the need for rapid and accurate diagnostic tools. The MRSA PCR Detection Kit, with its high sensitivity and specificity, has emerged as a preferred choice for healthcare professionals, thereby bolstering its market growth.

Impact of Industry Transitions on the Mrsa Pcr Detection Kit Market

As a core segment of the Biotechnology industry, the Mrsa Pcr Detection Kit market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements and Regulatory Changes have redefined priorities across the Biotechnology sector, influencing how the Mrsa Pcr Detection Kit market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Technological Advancements:

The MRSA PCR Detection Kit industry has witnessed significant technological advancements. High-throughput PCR systems have transformed MRSA detection and diagnosis through their ability to deliver faster and more precise results. The MRSA detection industry benefits from these advancements which create broader impacts on healthcare and diagnostic practices. The advancement of PCR systems leads to better patient care while shortening hospital stays and lowering healthcare expenses. The MRSA PCR Detection Kitindustry'sshift toward advanced technologies established a new benchmark for infectious disease diagnostic procedures.

2

Regulatory Changes:

The MRSA PCR Detection Kit industry has also experienced major shifts due to regulatory changes. Stricter regulations and guidelines for MRSA detection have led to the development of more reliable and efficient PCR detection kits. These changes have had a profound impact on associated industries such as pharmaceuticals and medical devices, necessitating the need for more rigorous testing and quality control measures. The transition driven by regulatory changes has significantly elevated the quality and reliability of MRSA PCR Detection Kits, thereby enhancing patient safety and healthcare outcomes.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Biotechnology industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Biotechnology industry cascade into the Mrsa Pcr Detection Kit market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Rising Incidence of MRSA Infections, and Increased Healthcare Expenditure and Awareness

The worldwide increase of Methicillin-resistant Staphylococcus aureus infections also creates a major market opportunity for the MRSA PCR Detection Kit. The MRSA PCR Detection Kit will also experience rising demand because MRSA infections are also becoming more widespread. The MRSA PCR Detection Kit enables fast MRSA detection in clinical samples which leads to immediate treatment and limits the spread of antibiotic-resistant bacteria.
The rise in healthcare expenditure and growing awareness about the risks associated with MRSA infections are also also contributing to the market expansion of the MRSA PCR Detection Kit. As healthcare systems globally prioritize infection control and patient safety, the utilization of sophisticated diagnostic tools like the MRSA PCR Detection Kit is also anticipated to rise, fostering market growth.
The development of Polymerase Chain Reaction techniques such as real-time PCR and multiplex PCR has also improved the ability to detect and diagnose MRSA. The MRSA PCR Detection Kit utilizes these advanced techniques to enhance MRSA detection sensitivity and specificity which also drives market growth.

Restraint: High Cost of MRSA PCR Detection Kits

The high cost of MRSA PCR Detection Kits is a significant in the market. These kits are priced higher than traditional diagnostic methods because of the advanced technology used in them. This high cost can deter potential customers, particularly in developing regions where healthcare budgets are limited, thereby negatively impacting market demand.

Challenge: Lack of Awareness and Technical Expertise

Another major is the lack of awareness about the benefits of MRSA PCR Detection Kits and the technical expertise required to use them. In many regions, healthcare professionals may not only be fully aware of the advantages of these kits over conventional diagnostic methods. Additionally, the technical skills needed to accurately use these kits can also pose a challenge, as not only all healthcare facilities have personnel trained in molecular diagnostic techniques. This lack of awareness and technical expertise can hinder market growth and demand for MRSA PCR Detection Kits.

Supply Chain Landscape

Raw Material Procurement

Thermo Fisher Scientific

Roche Diagnostics

Kit Assembly & Packaging

Becton Dickinson and Company

QIAGEN

Distribution & Logistics
McKesson Corporation / Cardinal Health
End User
Clinical Laboratories / Hospital Diagnostic Centers
Raw Material Procurement

Thermo Fisher Scientific

Roche Diagnostics

Kit Assembly & Packaging

Becton Dickinson and Company

QIAGEN

Distribution & Logistics

McKesson Corporation

Cardinal Health

End User

Clinical Laboratories

Hospital Diagnostic Centers

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Clinical Diagnostics
Healthcare
Roche Diagnostics
Focus on high sensitivity and specificity in MRSA detection kits, along with rapid turnaround times
Food Safety Testing
Food and Beverage
Thermo Fisher Scientific
Development of robust, reliable, and rapid MRSA PCR Detection Kits for food safety testing
Veterinary Diagnostics
Animal Health
Bio-Rad Laboratories
Emphasis on accurate and quick detection of MRSA in animals to prevent transmission to humans
Pharmaceutical Quality Control
Pharmaceuticals
Qiagen
Innovation in MRSA PCR Detection Kits for stringent quality control in drug manufacturing

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Mrsa Pcr Detection Kit market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Mrsa Pcr Detection Kit in Research & Development, Clinical Diagnostics and Food Safety Testing

Research & Development

In the realm of research and development, the MRSA PCR Detection Kit plays a pivotal role in studying the epidemiology of MRSA. Here, multiplex PCR detection kits are predominantly used due to their ability to simultaneously detect multiple genes. Key players in this application are research institutions and universities, which are known for their extensive research capabilities and strong market presence.

Clinical Diagnostics

The MRSA PCR Detection Kit is widely used in clinical diagnostics for the rapid identification of Methicillin-resistant Staphylococcus aureus in patient samples. This application primarily utilizes real-time PCR detection kits, which provide high sensitivity and specificity. Top players in this application include renowned biotechnology companies that have pioneered the development of these kits, leveraging their strengths in innovation and their robust market position.

Food Safety Testing

The MRSA PCR Detection Kit is also employed in food safety testing to detect and quantify MRSA in food samples. The real-time PCR detection kits are commonly used in this application for their rapid and accurate results. The top players in this application are food testing laboratories and companies that have a strong foothold in the market due to their comprehensive testing services and high-quality standards.

Mrsa Pcr Detection Kit vs. Substitutes:
Performance and Positioning Analysis

The MRSA PCR Detection Kit offers a rapid, reliable solution for detecting Methicillin-resistant Staphylococcus aureus, outperforming traditional culture methods in speed and accuracy. Its unique market positioning lies in its potential to revolutionize infectious disease diagnostics

Mrsa Pcr Detection Kit
  • Rapid MRSA Test Kits /
  • Next Generation Sequencing for MRSA Identification
    •High sensitivity and specificity, Rapid and accurate detection
    •Requires specialized equipment, High cost
    •High sensitivity and specificity, rapid results
    •High cost, technical expertise required

Mrsa Pcr Detection Kit vs. Substitutes:
Performance and Positioning Analysis

Mrsa Pcr Detection Kit

  • High sensitivity and specificity, Rapid and accurate detection
  • Requires specialized equipment, High cost

Rapid MRSA Test Kits / Next Generation Sequencing for MRSA Identification

  • High sensitivity and specificity, rapid results
  • High cost, technical expertise required

The MRSA PCR Detection Kit offers a rapid, reliable solution for detecting Methicillin-resistant Staphylococcus aureus, outperforming traditional culture methods in speed and accuracy. Its unique market positioning lies in its potential to revolutionize infectious disease diagnostics

Loading...

Research Methodology

This market research methodology defines the Mrsa Pcr Detection Kit market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Biotechnology ecosystem, we analyze Mrsa Pcr Detection Kit across Clinical Diagnostics, Research Laboratories, and Pharmaceutical Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Thermo Fisher Scientific Inc., QIAGEN N.V., and F. Hoffmann-La Roche Ltd. by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Procurement, Kit Assembly & Packaging, and Distribution & Logistics. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Biotechnology revenues to estimate the Mrsa Pcr Detection Kit segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Procurement (Thermo Fisher Scientific, Roche Diagnostics), Kit Assembly & Packaging (Becton Dickinson and Company, QIAGEN), and Distribution & Logistics. Our parallel substitute analysis examines Rapid MRSA Test Kits and Next Generation Sequencing for MRSA Identification, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Thermo Fisher Scientific Inc., QIAGEN N.V., and F. Hoffmann-La Roche Ltd., analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Mrsa Pcr Detection Kit market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Mrsa Pcr Detection Kit Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 1.3 billion
Revenue Forecast in 2034USD 2.5 billion
Growth RateCAGR of 7.4% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 20241.2 billion
Growth OpportunityUSD 1.3 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20241.2 billion USD
Market Size 20271.5 billion USD
Market Size 20291.8 billion USD
Market Size 20301.9 billion USD
Market Size 20342.5 billion USD
Market Size 20352.7 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredProduct Type, Applications, Technology, Sensitivity
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledThermo Fisher Scientific Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., bioMrieux SA, BD (Becton Dickinson and Company), Cepheid Inc., Abbott Laboratories, Meridian Bioscience Inc., GenMark Diagnostics Inc., Luminex Corporation, Hologic Inc. and Seegene Inc.
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • •Assess and prioritize high-value markets with precision
  • •Craft tailored entry and expansion roadmaps
  • •De-risk investments through rigorous market intelligence
  • •Architect dynamic pricing frameworks aligned to value creation
  • •Unlock sustainable margin enhancement opportunities
  • •Benchmark performance against global industry leaders
  • •Strategically realign portfolios to future growth drivers
  • •Accelerate commercialization of breakthrough offerings
  • •Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Mrsa Pcr Detection Kit Market Size, Opportunities & Strategic Insights, by Product Type

4.1Real-Time
4.2Conventional
4.3Digital
Chapter 5

Mrsa Pcr Detection Kit Market Size, Opportunities & Strategic Insights, by Applications

5.1Clinical Diagnostics
5.2Research Laboratories
5.3Pharmaceutical
5.4Forensic Laboratories
5.5Others
Chapter 6

Mrsa Pcr Detection Kit Market Size, Opportunities & Strategic Insights, by Technology

6.1Multiplex
6.2Quantitative
6.3Reverse Transcriptase
Chapter 7

Mrsa Pcr Detection Kit Market Size, Opportunities & Strategic Insights, by Sensitivity

7.1High Sensitivity
7.2Moderate Sensitivity
7.3Low Sensitivity
Chapter 8

Mrsa Pcr Detection Kit Market, by Region

8.1North America Mrsa Pcr Detection Kit Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Mrsa Pcr Detection Kit Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Mrsa Pcr Detection Kit Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Mrsa Pcr Detection Kit Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Mrsa Pcr Detection Kit Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Mrsa Pcr Detection Kit Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Thermo Fisher Scientific Inc.
9.2.2QIAGEN N.V.
9.2.3F. Hoffmann-La Roche Ltd.
9.2.4bioMrieux SA
9.2.5BD (Becton Dickinson and Company)
9.2.6Cepheid Inc.
9.2.7Abbott Laboratories
9.2.8Meridian Bioscience Inc.
9.2.9GenMark Diagnostics Inc.
9.2.10Luminex Corporation
9.2.11Hologic Inc.
9.2.12Seegene Inc.